tiprankstipranks
Trending News
More News >
Ascentage Pharma Group International (HK:6855)
:6855
Hong Kong Market
Advertisement

Ascentage Pharma Group International (6855) Income Statement

Compare
1 Followers

Ascentage Pharma Group International Income Statement

Last quarter (Q4 2024), Ascentage Pharma Group International's total revenue was ¥156.90M, an increase of 37.70% from the same quarter last year. In Q4, Ascentage Pharma Group International's net income was ¥-568.43M. See Ascentage Pharma Group International’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
¥ 980.65M¥ 221.98M¥ 209.71M¥ 27.91M¥ 12.45M
Gross Profit
¥ 951.57M¥ 191.44M¥ 187.71M¥ 24.58M¥ 10.48M
Operating Expenses
¥ 1.32B¥ 191.44M¥ 1.03B¥ 847.21M¥ 684.89M
Depreciation and Amortization
¥ 79.17M¥ 93.19M¥ 62.91M¥ 28.33M¥ 27.42M
EBITDA
¥ -299.63M¥ -743.61M¥ -835.99M¥ -915.99M¥ -641.77M
Operating Income
¥ -378.80M¥ -891.99M¥ -883.41M¥ -933.17M¥ -684.43M
Other Income/Expenses
¥ -16.45M¥ -40.87M¥ -37.36M¥ 37.59M¥ -11.51M
Pretax Income
¥ -395.25M¥ -932.86M¥ -887.17M¥ -832.25M¥ -675.45M
Net Income
¥ -405.43M¥ -925.64M¥ -882.92M¥ -782.42M¥ -677.61M
Per Share Metrics
Basic EPS
¥ -1.34¥ -3.28¥ -3.35¥ -3.07¥ -3.14
Diluted EPS
¥ -1.34¥ -3.28¥ -3.35¥ -3.07¥ -3.14
Weighted Average Shares Outstanding
302.06M 282.30M 263.67M 254.62M 215.91M
Weighted Average Shares Outstanding (Diluted)
302.06M 282.30M 263.67M 254.62M 215.91M
Currency in CNY

Ascentage Pharma Group International Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis